Table 2.
Patient | Sample Type | Pathogen | Reads | Contigs | Coverage | Depth |
---|---|---|---|---|---|---|
1 | Serum | Clostridium sp. | 6554 | 1 | 0.8% | 0.25× |
2 | Tempus | E. coli | 63 | 1 | 0.1% | 0.005× |
3 | Whole blood | DENV-2 | 72,078 | 3 | 99.8% | 1145× |
4 | Whole blood | E. coli | 6939 | 1 | 0.1% | 0.61× |
5 | Serum | E. coli | 10,968 | 1 | 0.3% | 1× |
6 | Whole blood | HPgV | 511 | 2 | 86.2% | 41× |
E. coli | 4635 | 1 | 0.4% | 0.18× | ||
7 | Streptococcus sp. | 1347 | 1 | 0.1% | 0.17× | |
Tempus | E. coli | 173 | 1 | 0.7% | 0.012× | |
Serum | E. coli | 9889 | 1 | 0.1% | 0.95× | |
8 | Whole blood | E. coli | 5280 | 1 | 0.1% | 0.41× |
9 | Serum | HIV-1 | 52,420 | 2 | 92% | 1805× |
E. coli | 13,778 | 1 | 0.2% | 1.2× | ||
10 | Serum | E. coli | 22,622 | 1 | 0.1% | 1.6× |
11 | Cerebrospinal fluid 1 | E. coli | 2084 | 1 | 0.1% | 0.19× |
Cerebrospinal fluid 2 | E. coli | 1703 | 1 | 0.2% | 0.11× | |
12 | Whole blood | - | - | - | - | - |
13 | Negative control | E. coli | 27 | 0 | - | - |